Serum-free Systems

  • Lower risk of contamination with bacteria, fungi, mycoplasma or virus
  • Defined and reproducible formulations result in more convincing and comparable research data
  • Time-consuming batch tests are dispensable
  • Elimination of a source for possible infectious agents (prions)
  • Ease of purification of end products
  • Fulfilment of legal requirements for the manufacturing of medical products
  • Reduction of impurities in end products by culture residues